| scholarly article | Q13442814 |
| P50 | author | Markus R. Wenk | Q90987707 |
| Christoph Handschin | Q14865377 | ||
| P2093 | author name string | Guanghou Shui | |
| Serge Summermatter | |||
| Gesa Santos | |||
| Daniela Maag | |||
| P2860 | cites work | Metabolomic response to exercise training in lean and diet-induced obese mice. | Q51609397 |
| Coordinated balancing of muscle oxidative metabolism through PGC-1α increases metabolic flexibility and preserves insulin sensitivity. | Q53253436 | ||
| Lipid composition of sarcoplasmic reticulum of human skeletal muscle. | Q54508394 | ||
| Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial | Q57404688 | ||
| HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α | Q59066890 | ||
| Role of exercise-training in the prevention of hyperinsulinemia caused by high energy diet | Q70431369 | ||
| A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance | Q77652485 | ||
| Strain-dependent differences in responses to exercise training in inbred and hybrid mice | Q81196321 | ||
| Toward one step analysis of cellular lipidomes using liquid chromatography coupled with mass spectrometry: application to Saccharomyces cerevisiae and Schizosaccharomyces pombe lipidomics | Q84261451 | ||
| 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. | Q22241393 | ||
| PGC-1 coactivators: inducible regulators of energy metabolism in health and disease | Q24541524 | ||
| Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 | Q24679555 | ||
| Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1 | Q28131760 | ||
| Remodeling of calcium handling in skeletal muscle through PGC-1α: impact on force, fatigability, and fiber type | Q28248050 | ||
| Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism | Q28266830 | ||
| PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes | Q29547229 | ||
| Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres | Q29555845 | ||
| Obesity as a medical problem | Q29616305 | ||
| AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism | Q29617261 | ||
| Reactive oxygen species have a causal role in multiple forms of insulin resistance | Q29619831 | ||
| Sphingosine, an inhibitor of protein kinase C, suppresses the insulin-like effects of growth hormone in rat adipocytes. | Q33864021 | ||
| PGC-1α and exercise in the control of body weight. | Q34030453 | ||
| Peroxisome proliferator-activated receptor {gamma} coactivator 1{alpha} (PGC-1{alpha}) promotes skeletal muscle lipid refueling in vivo by activating de novo lipogenesis and the pentose phosphate pathway. | Q34236724 | ||
| Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes? | Q35227175 | ||
| Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. | Q35710041 | ||
| Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk | Q36025294 | ||
| The role of exercise and PGC1alpha in inflammation and chronic disease | Q36984669 | ||
| Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism | Q37006469 | ||
| Lipid signalling in disease. | Q37064018 | ||
| Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. | Q37271487 | ||
| AMPK: an emerging drug target for diabetes and the metabolic syndrome | Q37471010 | ||
| The biology of PGC-1α and its therapeutic potential | Q37484604 | ||
| Lack of adequate appreciation of physical exercise's complexities can pre-empt appropriate design and interpretation in scientific discovery | Q37590547 | ||
| The effect of physical activity on body weight | Q37635750 | ||
| Relationship between costs of lifestyle interventions and weight loss in overweight adults | Q37642038 | ||
| Endurance exercise mimetics in skeletal muscle | Q37771820 | ||
| Modulation of protein kinase C and diverse cell functions by sphingosine--a pharmacologically interesting compound linking sphingolipids and signal transduction | Q38598657 | ||
| Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. | Q39575996 | ||
| Overactivation of NF-κB impairs insulin sensitivity and mediates palmitate-induced insulin resistance in C2C12 skeletal muscle cells | Q39641625 | ||
| Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance | Q40028148 | ||
| Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans | Q42247172 | ||
| Role of fatty acid synthesis in the control of insulin-stimulated glucose utilization by rat adipocytes | Q42467309 | ||
| Insulin-stimulated hexose transport and glucose oxidation in rat adipocytes is inhibited by sphingosine at a step after insulin binding. | Q42496831 | ||
| Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle | Q43555519 | ||
| Interaction of diet and training on endurance performance in rats. | Q43668623 | ||
| Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes | Q43819832 | ||
| Peripheral insulin sensitivity as modified by diet and exercise training | Q46121189 | ||
| Time course of the effects of a high-fat diet and voluntary exercise on muscle enzyme activity in Long-Evans rats | Q46219900 | ||
| Muscle-specific expression of PPARgamma coactivator-1alpha improves exercise performance and increases peak oxygen uptake | Q46779772 | ||
| A role for the transcriptional coactivator PGC-1alpha in muscle refueling | Q46954472 | ||
| Insulin binding and hexose transport in rat adipocytes. Relation to cell size | Q47291743 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glucose | Q37525 |
| glycobiology | Q899224 | ||
| P1104 | number of pages | 11 | |
| P304 | page(s) | 85-95 | |
| P577 | publication date | 2012-10-18 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | PGC-1α improves glucose homeostasis in skeletal muscle in an activity-dependent manner | |
| P478 | volume | 62 |
| Q57278736 | A marker-derived gene network reveals the regulatory role of PPARGC1A, HNF4G, and FOXP3 in intramuscular fat deposition of beef cattle1 |
| Q26776446 | Caloric restriction and exercise "mimetics'': Ready for prime time? |
| Q38602833 | Candidate genes for male and female reproductive traits in Canchim beef cattle |
| Q38945649 | Combatting type 2 diabetes by turning up the heat |
| Q26776167 | Complex Coordination of Cell Plasticity by a PGC-1α-controlled Transcriptional Network in Skeletal Muscle |
| Q92833063 | Constitutive PGC-1α overexpression in skeletal muscle does not protect from age-dependent decline in neurogenesis |
| Q37002690 | Distinct populations of adipogenic and myogenic Myf5-lineage progenitors in white adipose tissues. |
| Q90561607 | Dynamic enhancers control skeletal muscle identity and reprogramming |
| Q37055507 | Exercise Increases and Browns Muscle Lipid in High-Fat Diet-Fed Mice |
| Q92025368 | Exercise and Mitochondrial Remodeling in Skeletal Muscle in Type 2 Diabetes |
| Q37586770 | Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways |
| Q36933850 | Exercise-like effects by Estrogen-related receptor-gamma in muscle do not prevent insulin resistance in db/db mice. |
| Q64236148 | Fibroblast Growth Factor 21 and Browning of White Adipose Tissue |
| Q94586219 | Functional effects of muscle PGC-1alpha in aged animals |
| Q37619755 | Genetic models of PGC-1 and glucose metabolism and homeostasis |
| Q64079223 | Hepatoprotective Effects of Silymarin on Liver Injury via Irisin Upregulation and Oxidative Stress Reduction in Rats with Type 2 Diabetes |
| Q33816920 | Loss of Pgc-1α expression in aging mouse muscle potentiates glucose intolerance and systemic inflammation |
| Q36004415 | Mitochondrial quality control, promoted by PGC-1α, is dysregulated by Western diet-induced obesity and partially restored by moderate physical activity in mice |
| Q36839551 | Morphological and functional remodelling of the neuromuscular junction by skeletal muscle PGC-1α |
| Q35532249 | Muscle-Specific Overexpression of PGC-1α Does Not Augment Metabolic Improvements in Response to Exercise and Caloric Restriction |
| Q42172798 | Muscle-specific activation of Ca(2+)/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice. |
| Q39261747 | Myobolites: muscle-derived metabolites with paracrine and systemic effects |
| Q47811763 | Pharmacological targeting of exercise adaptations in skeletal muscle: Benefits and pitfalls |
| Q42021139 | Regulation of glycemic control by physical activity: a role for mitochondria? |
| Q41446819 | Resistance training regulates gene expression of molecules associated with intramyocellular lipids, glucose signaling and fiber size in old rats |
| Q34925298 | Short term exercise induces PGC-1α, ameliorates inflammation and increases mitochondrial membrane proteins but fails to increase respiratory enzymes in aging diabetic hearts |
| Q99562765 | Simvastatin Impairs Glucose Homeostasis in Mice Depending on PGC-1α Skeletal Muscle Expression |
| Q39208622 | Sirtuin 1-mediated effects of exercise and resveratrol on mitochondrial biogenesis |
| Q26785313 | Skeletal muscle as an endocrine organ: PGC-1α, myokines and exercise |
| Q38905640 | Skeletal muscle mitochondria as a target to prevent or treat type 2 diabetes mellitus |
| Q92130953 | Tankyrase inhibition ameliorates lipid disorder via suppression of PGC-1α PARylation in db/db mice |
| Q45462968 | The Implication of PGC-1α on Fatty Acid Transport across Plasma and Mitochondrial Membranes in the Insulin Sensitive Tissues. |
| Q38322773 | The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases. |
| Q36310530 | The coactivator PGC-1α regulates skeletal muscle oxidative metabolism independently of the nuclear receptor PPARβ/δ in sedentary mice fed a regular chow diet |
| Q38190176 | The many roles of PGC-1α in muscle--recent developments |
| Q34056556 | Transcriptional network analysis in muscle reveals AP-1 as a partner of PGC-1α in the regulation of the hypoxic gene program |
| Q55260615 | Transcriptional regulation of metabolism in disease: From transcription factors to epigenetics. |
| Q92135721 | Transcriptomic Responses of Skeletal Muscle to Acute Exercise in Diabetic Goto-Kakizaki Rats |
Search more.